A dual-threat cancer drug takes aim at resistance mechanisms Judy Sebolt-Leopold and her team at MEKanistic Therapeutics developed a single molecule targeting two kinase enzymes that drive resistance to cancer therapies.

https://www.drugdiscoverynews.com/a-dual-threat-cancer-drug-takes-aim-at-resistance-mechanisms-16267